Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection.
Yu-Hui LiuQuan-Xin WuQing-Hua WangQiao-Feng ZhangYi TangDi LiuJing-Juan WangXiao-Yu LiuLing-Ru WangLi LiCheng XuJie ZhuYan-Jiang WangPublished in: Nature aging (2024)
Emerging evidence suggests that neurological and other post-acute sequelae of COVID-19 can persist beyond or develop following SARS-CoV-2 infection. However, the long-term trajectories of cognitive change after a COVID-19 infection remain unclear. Here we investigated cognitive changes over a period of 2.5 years among 1,245 individuals aged 60 years or older who survived infection with the original SARS-CoV-2 strain in Wuhan, China, and 358 uninfected spouses. We show that the overall incidence of cognitive impairment among older COVID-19 survivors was 19.1% at 2.5 years after infection and hospitalization, evaluated using the Telephone Interview for Cognitive Status-40. Cognitive decline primarily manifested in individuals with severe COVID-19 during the initial year of infection, after which the rate of decline decelerated. Severe COVID-19, cognitive impairment at 6 months and hypertension were associated with long-term cognitive decline. These findings reveal the long-term cognitive trajectory of the disease and underscore the importance of post-infection cognitive care for COVID-19 survivors.
Keyphrases
- sars cov
- coronavirus disease
- cognitive decline
- respiratory syndrome coronavirus
- cognitive impairment
- mild cognitive impairment
- young adults
- depressive symptoms
- physical activity
- gene expression
- middle aged
- palliative care
- intensive care unit
- early onset
- dna methylation
- high resolution
- genome wide
- subarachnoid hemorrhage
- single cell
- extracorporeal membrane oxygenation
- health insurance
- respiratory failure
- mechanical ventilation